Europe Kidney Cancer Drug Market Report 2016

September 2016 | 123 pages | ID: EF15739A965EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Kidney Cancer Drug

Revenue, means the sales value of Kidney Cancer Drug

This report studies sales (consumption) of Kidney Cancer Drug in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Bayer
• F. Hoffmann-La Roche
• GlaxoSmithKline
• Novartis
• Pfizer
• Abbott Laboratories
• Active Biotech
• Amgen
• Argos Therapeutics
• ArQule
• AVEO Pharmaceuticals
• Bionomics
• Bristol-Myers Squibb
• Cerulean Pharma
• Exelixis
• Genentech
• immatics biotechnologies
• Immunicum
• Ono Pharmaceutical
• Onyx Therapeutics
• Oxford BioMedica
• Prometheus Laboratories
• Seattle Genetics
• Taiwan Liposome
• TRACON Pharmaceuticals
• Wilex

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Kidney Cancer Drug in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Kidney Cancer Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Europe Kidney Cancer Drug Market Report 2016

1 KIDNEY CANCER DRUG OVERVIEW

1.1 Product Overview and Scope of Kidney Cancer Drug
1.2 Classification of Kidney Cancer Drug
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Kidney Cancer Drug
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Kidney Cancer Drug Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Kidney Cancer Drug (2011-2021)
  1.5.1 Europe Kidney Cancer Drug Sales and Growth Rate (2011-2021)
  1.5.2 Europe Kidney Cancer Drug Revenue and Growth Rate (2011-2021)

2 EUROPE KIDNEY CANCER DRUG BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Kidney Cancer Drug Market Competition by Manufacturers
  2.1.1 Europe Kidney Cancer Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Kidney Cancer Drug Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Kidney Cancer Drug (Volume and Value) by Type
  2.2.1 Europe Kidney Cancer Drug Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Kidney Cancer Drug Revenue and Market Share by Type (2011-2016)
2.3 Europe Kidney Cancer Drug (Volume and Value) by Countries
  2.3.1 Europe Kidney Cancer Drug Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Kidney Cancer Drug Revenue and Market Share by Countries (2011-2016)
2.4 Europe Kidney Cancer Drug (Volume) by Application

3 GERMANY KIDNEY CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Kidney Cancer Drug Sales and Value (2011-2016)
  3.1.1 Germany Kidney Cancer Drug Sales and Growth Rate (2011-2016)
  3.1.2 Germany Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Kidney Cancer Drug Sales Price Trend (2011-2016)
3.2 Germany Kidney Cancer Drug Sales and Market Share by Manufacturers
3.3 Germany Kidney Cancer Drug Sales and Market Share by Type
3.4 Germany Kidney Cancer Drug Sales and Market Share by Application

4 FRANCE KIDNEY CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 France Kidney Cancer Drug Sales and Value (2011-2016)
  4.1.1 France Kidney Cancer Drug Sales and Growth Rate (2011-2016)
  4.1.2 France Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
  4.1.4 France Kidney Cancer Drug Sales Price Trend (2011-2016)
4.2 France Kidney Cancer Drug Sales and Market Share by Manufacturers
4.3 France Kidney Cancer Drug Sales and Market Share by Type
4.4 France Kidney Cancer Drug Sales and Market Share by Application

5 UK KIDNEY CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 UK Kidney Cancer Drug Sales and Value (2011-2016)
  5.1.1 UK Kidney Cancer Drug Sales and Growth Rate (2011-2016)
  5.1.2 UK Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
  5.1.5 UK Kidney Cancer Drug Sales Price Trend (2011-2016)
5.2 UK Kidney Cancer Drug Sales and Market Share by Manufacturers
5.3 UK Kidney Cancer Drug Sales and Market Share by Type
5.4 UK Kidney Cancer Drug Sales and Market Share by Application

6 RUSSIA KIDNEY CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Kidney Cancer Drug Sales and Value (2011-2016)
  6.1.1 Russia Kidney Cancer Drug Sales and Growth Rate (2011-2016)
  6.1.2 Russia Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Kidney Cancer Drug Sales Price Trend (2011-2016)
6.2 Russia Kidney Cancer Drug Sales and Market Share by Manufacturers
6.3 Russia Kidney Cancer Drug Sales and Market Share by Type
6.4 Russia Kidney Cancer Drug Sales and Market Share by Application

7 ITALY KIDNEY CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Kidney Cancer Drug Sales and Value (2011-2016)
  7.1.1 Italy Kidney Cancer Drug Sales and Growth Rate (2011-2016)
  7.1.2 Italy Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Kidney Cancer Drug Sales Price Trend (2011-2016)
7.2 Italy Kidney Cancer Drug Sales and Market Share by Manufacturers
7.3 Italy Kidney Cancer Drug Sales and Market Share by Type
7.4 Italy Kidney Cancer Drug Sales and Market Share by Application

8 SPAIN KIDNEY CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Kidney Cancer Drug Sales and Value (2011-2016)
  8.1.1 Spain Kidney Cancer Drug Sales and Growth Rate (2011-2016)
  8.1.2 Spain Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Kidney Cancer Drug Sales Price Trend (2011-2016)
8.2 Spain Kidney Cancer Drug Sales and Market Share by Manufacturers
8.3 Spain Kidney Cancer Drug Sales and Market Share by Type
8.4 Spain Kidney Cancer Drug Sales and Market Share by Application

9 BENELUX KIDNEY CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Kidney Cancer Drug Sales and Value (2011-2016)
  9.1.1 Benelux Kidney Cancer Drug Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Kidney Cancer Drug Sales Price Trend (2011-2016)
9.2 Benelux Kidney Cancer Drug Sales and Market Share by Manufacturers
9.3 Benelux Kidney Cancer Drug Sales and Market Share by Type
9.4 Benelux Kidney Cancer Drug Sales and Market Share by Application

10 EUROPE KIDNEY CANCER DRUG MANUFACTURERS ANALYSIS

10.1 Bayer
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Kidney Cancer Drug Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Bayer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 F. Hoffmann-La Roche
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Kidney Cancer Drug Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 F. Hoffmann-La Roche Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 GlaxoSmithKline
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Kidney Cancer Drug Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 GlaxoSmithKline Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Novartis
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Kidney Cancer Drug Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Novartis Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Pfizer
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Kidney Cancer Drug Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Pfizer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Abbott Laboratories
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Kidney Cancer Drug Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Abbott Laboratories Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Active Biotech
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Kidney Cancer Drug Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Active Biotech Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Amgen
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Kidney Cancer Drug Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Amgen Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Argos Therapeutics
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Kidney Cancer Drug Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Argos Therapeutics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 ArQule
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Kidney Cancer Drug Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 ArQule Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 AVEO Pharmaceuticals
10.12 Bionomics
10.13 Bristol-Myers Squibb
10.14 Cerulean Pharma
10.15 Exelixis
10.16 Genentech
10.17 immatics biotechnologies
10.18 Immunicum
10.19 Ono Pharmaceutical
10.20 Onyx Therapeutics
10.21 Oxford BioMedica
10.22 Prometheus Laboratories
10.23 Seattle Genetics
10.24 Taiwan Liposome
10.25 TRACON Pharmaceuticals
10.26 Wilex

11 KIDNEY CANCER DRUG MANUFACTURING COST ANALYSIS

11.1 Kidney Cancer Drug Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Kidney Cancer Drug

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Kidney Cancer Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Kidney Cancer Drug Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE KIDNEY CANCER DRUG MARKET FORECAST (2016-2021)

14.1 Germany Kidney Cancer Drug Sales Forecast (2016-2021)
14.2 France Kidney Cancer Drug Sales Forecast (2016-2021)
14.3 UK Kidney Cancer Drug Sales Forecast (2016-2021)
14.4 Russia Kidney Cancer Drug Sales Forecast (2016-2021)
14.5 Italy Kidney Cancer Drug Sales Forecast (2016-2021)
14.6 Spain Kidney Cancer Drug Sales Forecast (2016-2021)
14.7 Benelux Kidney Cancer Drug Sales Forecast (2016-2021)
14.8 Europe Kidney Cancer Drug Sales Forecast by Type (2016-2021)
14.9 Europe Kidney Cancer Drug Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Kidney Cancer Drug
Table Classification of Kidney Cancer Drug
Figure Europe Sales Market Share of Kidney Cancer Drug by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Kidney Cancer Drug
Figure Europe Sales Market Share of Kidney Cancer Drug by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Figure France Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Figure UK Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Figure Russia Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Figure Italy Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Figure Spain Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Figure Benelux Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Figure Europe Kidney Cancer Drug Sales and Growth Rate (2011-2021)
Figure Europe Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Table Europe Kidney Cancer Drug Sales of Key Manufacturers (2015 and 2016)
Table Europe Kidney Cancer Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Kidney Cancer Drug Sales Share by Manufacturers
Figure 2016 Kidney Cancer Drug Sales Share by Manufacturers
Table Europe Kidney Cancer Drug Revenue by Manufacturers (2015 and 2016)
Table Europe Kidney Cancer Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Kidney Cancer Drug Revenue Share by Manufacturers
Table 2016 Europe Kidney Cancer Drug Revenue Share by Manufacturers
Table Europe Kidney Cancer Drug Sales and Market Share by Type (2011-2016)
Table Europe Kidney Cancer Drug Sales Share by Type (2011-2016)
Figure Sales Market Share of Kidney Cancer Drug by Type (2011-2016)
Figure Europe Kidney Cancer Drug Sales Growth Rate by Type (2011-2016)
Table Europe Kidney Cancer Drug Revenue and Market Share by Type (2011-2016)
Table Europe Kidney Cancer Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Kidney Cancer Drug by Type (2011-2016)
Figure Europe Kidney Cancer Drug Revenue Growth Rate by Type (2011-2016)
Table Europe Kidney Cancer Drug Sales and Market Share by Countries (2011-2016)
Table Europe Kidney Cancer Drug Sales Share by Countries (2011-2016)
Figure Sales Market Share of Kidney Cancer Drug by Countries (2011-2016)
Table Europe Kidney Cancer Drug Revenue and Market Share by Countries (2011-2016)
Table Europe Kidney Cancer Drug Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Kidney Cancer Drug by Countries (2011-2016)
Table Europe Kidney Cancer Drug Sales and Market Share by Application (2011-2016)
Table Europe Kidney Cancer Drug Sales Share by Application (2011-2016)
Figure Sales Market Share of Kidney Cancer Drug by Application (2011-2016)
Figure Germany Kidney Cancer Drug Sales and Growth Rate (2011-2016)
Figure Germany Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
Figure Germany Kidney Cancer Drug Sales Price Trend (2011-2016)
Table Germany Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)
Table Germany Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)
Table Germany Kidney Cancer Drug Sales by Type (2015 and 2016)
Table Germany Kidney Cancer Drug Market Share by Type (2015 and 2016)
Table Germany Kidney Cancer Drug Sales by Application (2015 and 2016)
Table Germany Kidney Cancer Drug Market Share by Application (2015 and 2016)
Figure France Kidney Cancer Drug Sales and Growth Rate (2011-2016)
Figure France Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
Figure France Kidney Cancer Drug Sales Price Trend (2011-2016)
Table France Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)
Table France Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)
Table France Kidney Cancer Drug Sales by Type (2015 and 2016)
Table France Kidney Cancer Drug Market Share by Type (2015 and 2016)
Table France Kidney Cancer Drug Sales by Application (2015 and 2016)
Table France Kidney Cancer Drug Market Share by Application (2015 and 2016)
Figure UK Kidney Cancer Drug Sales and Growth Rate (2011-2016)
Figure UK Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
Figure UK Kidney Cancer Drug Sales Price Trend (2011-2016)
Table UK Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)
Table UK Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)
Table UK Kidney Cancer Drug Sales by Type (2015 and 2016)
Table UK Kidney Cancer Drug Market Share by Type (2015 and 2016)
Table UK Kidney Cancer Drug Sales by Application (2015 and 2016)
Table UK Kidney Cancer Drug Market Share by Application (2015 and 2016)
Figure Russia Kidney Cancer Drug Sales and Growth Rate (2011-2016)
Figure Russia Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
Figure Russia Kidney Cancer Drug Sales Price Trend (2011-2016)
Table Russia Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)
Table Russia Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)
Table Russia Kidney Cancer Drug Sales by Type (2015 and 2016)
Table Russia Kidney Cancer Drug Market Share by Type (2015 and 2016)
Table Russia Kidney Cancer Drug Sales by Application (2015 and 2016)
Table Russia Kidney Cancer Drug Market Share by Application (2015 and 2016)
Figure Italy Kidney Cancer Drug Sales and Growth Rate (2011-2016)
Figure Italy Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
Figure Italy Kidney Cancer Drug Sales Price Trend (2011-2016)
Table Italy Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)
Table Italy Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)
Table Italy Kidney Cancer Drug Sales by Type (2015 and 2016)
Table Italy Kidney Cancer Drug Market Share by Type (2015 and 2016)
Table Italy Kidney Cancer Drug Sales by Application (2015 and 2016)
Table Italy Kidney Cancer Drug Market Share by Application (2015 and 2016)
Figure Spain Kidney Cancer Drug Sales and Growth Rate (2011-2016)
Figure Spain Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
Figure Spain Kidney Cancer Drug Sales Price Trend (2011-2016)
Table Spain Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)
Table Spain Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)
Table Spain Kidney Cancer Drug Sales by Type (2015 and 2016)
Table Spain Kidney Cancer Drug Market Share by Type (2015 and 2016)
Table Spain Kidney Cancer Drug Sales by Application (2015 and 2016)
Table Spain Kidney Cancer Drug Market Share by Application (2015 and 2016)
Figure Benelux Kidney Cancer Drug Sales and Growth Rate (2011-2016)
Figure Benelux Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
Figure Benelux Kidney Cancer Drug Sales Price Trend (2011-2016)
Table Benelux Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)
Table Benelux Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)
Table Benelux Kidney Cancer Drug Sales by Type (2015 and 2016)
Table Benelux Kidney Cancer Drug Market Share by Type (2015 and 2016)
Table Benelux Kidney Cancer Drug Sales by Application (2015 and 2016)
Table Benelux Kidney Cancer Drug Market Share by Application (2015 and 2016)
Table Kidney Cancer Drug Basic Information List
Table Bayer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Kidney Cancer Drug Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Kidney Cancer Drug Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Kidney Cancer Drug Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Kidney Cancer Drug Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Kidney Cancer Drug Sales Market Share (2011-2016)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories Kidney Cancer Drug Sales Market Share (2011-2016)
Table Active Biotech Basic Information List
Table Active Biotech Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Active Biotech Kidney Cancer Drug Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Kidney Cancer Drug Sales Market Share (2011-2016)
Table Argos Therapeutics Basic Information List
Table Argos Therapeutics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Argos Therapeutics Kidney Cancer Drug Sales Market Share (2011-2016)
Table ArQule Basic Information List
Table ArQule Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table ArQule Kidney Cancer Drug Sales Market Share (2011-2016)
Table AVEO Pharmaceuticals Basic Information List
Table AVEO Pharmaceuticals Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table AVEO Pharmaceuticals Kidney Cancer Drug Sales Market Share (2011-2016)
Table Bionomics Basic Information List
Table Bionomics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bionomics Kidney Cancer Drug Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Kidney Cancer Drug Sales Market Share (2011-2016)
Table Cerulean Pharma Basic Information List
Table Cerulean Pharma Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cerulean Pharma Kidney Cancer Drug Sales Market Share (2011-2016)
Table Exelixis Basic Information List
Table Exelixis Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Exelixis Kidney Cancer Drug Sales Market Share (2011-2016)
Table Genentech Basic Information List
Table Genentech Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Kidney Cancer Drug Sales Market Share (2011-2016)
Table immatics biotechnologies Basic Information List
Table immatics biotechnologies Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table immatics biotechnologies Kidney Cancer Drug Sales Market Share (2011-2016)
Table Immunicum Basic Information List
Table Immunicum Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Immunicum Kidney Cancer Drug Sales Market Share (2011-2016)
Table Ono Pharmaceutical Basic Information List
Table Ono Pharmaceutical Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ono Pharmaceutical Kidney Cancer Drug Sales Market Share (2011-2016)
Table Onyx Therapeutics Basic Information List
Table Onyx Therapeutics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Onyx Therapeutics Kidney Cancer Drug Sales Market Share (2011-2016)
Table Oxford BioMedica Basic Information List
Table Oxford BioMedica Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Oxford BioMedica Kidney Cancer Drug Sales Market Share (2011-2016)
Table Prometheus Laboratories Basic Information List
Table Prometheus Laboratories Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Prometheus Laboratories Kidney Cancer Drug Sales Market Share (2011-2016)
Table Seattle Genetics Basic Information List
Table Seattle Genetics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Seattle Genetics Kidney Cancer Drug Sales Market Share (2011-2016)
Table Taiwan Liposome Basic Information List
Table Taiwan Liposome Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Taiwan Liposome Kidney Cancer Drug Sales Market Share (2011-2016)
Table TRACON Pharmaceuticals Basic Information List
Table TRACON Pharmaceuticals Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table TRACON Pharmaceuticals Kidney Cancer Drug Sales Market Share (2011-2016)
Table Wilex Basic Information List
Table Wilex Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Wilex Kidney Cancer Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Kidney Cancer Drug
Figure Manufacturing Process Analysis of Kidney Cancer Drug
Figure Kidney Cancer Drug Industrial Chain Analysis
Table Raw Materials Sources of Kidney Cancer Drug Major Manufacturers in 2015
Table Major Buyers of Kidney Cancer Drug
Table Distributors/Traders List
Figure Germany Kidney Cancer Drug Sales and Growth Rate Forecast (2016-2021)
Figure Germany Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)
Figure France Kidney Cancer Drug Sales and Growth Rate Forecast (2016-2021)
Figure France Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)
Figure UK Kidney Cancer Drug Sales and Growth Rate Forecast (2016-2021)
Figure UK Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Kidney Cancer Drug Sales and Growth Rate Forecast (2016-2021)
Figure Russia Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Kidney Cancer Drug Sales and Growth Rate Forecast (2016-2021)
Figure Italy Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Kidney Cancer Drug Sales and Growth Rate Forecast (2016-2021)
Figure Spain Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Kidney Cancer Drug Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)
Table Europe Kidney Cancer Drug Sales Forecast by Type (2016-2021)
Table Europe Kidney Cancer Drug Sales Forecast by Application (2016-2021)